# Galmed Pharmaceuticals Ltd. — Form D

Galmed Pharmaceuticals Ltd. of TEL AVIV, L3, a company, filed a Form D exempt-offering notice with the SEC on 2017-08-15. The offering totals $350K, of which $100K was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2017-08-15
- Form: D
- Accession: 0001144204-17-043518
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $350K
- Amount sold: $100K
- Remaining: $250K
- Investors: 1
- Date of first sale: 2017-08-09
- Security types: equity
- Revenue range: $1 - $1,000,000
- SEC file number: 021-292864

## Issuer

- Name: Galmed Pharmaceuticals Ltd.
- CIK: 0001595353
- Entity type: Corporation
- Jurisdiction: ISRAEL
- Incorporated: 2013
- Address: 16 TIOMKIN STREET, TEL AVIV, L3, 6578317
- Phone: 972 3 693 8448

## Officers, directors & promoters (12)

| Name | Role | Location |
| --- | --- | --- |
| Allen Baharaff | Director | Tel Aviv, L3 |
| Carol Brosgart | Director | Los Angeles, CA |
| Chaim Hurvitz | Director | Wilmington, DE |
| William Marth | Director | Tel Aviv, L3 |
| Shmuel Nir | Director | Tel Aviv, L3 |
| Ran Oren | Director | Tel Aviv, L3 |
| David Sidransky | Director | Germantown, MD |
| Tali Yaron-Eldar | Director | Tel Aviv, L3 |
| Allen Baharaff | Executive Officer | Tel Aviv, L3 |
| Tali Gorfine | Executive Officer | Tel Aviv, L3 |
| Liat Hayardeny | Executive Officer | Tel Aviv, L3 |
| Yohai Stenzler | Executive Officer | Tel Aviv, L3 |

## More

- [CIK 1595353 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1595353&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001144204-17-043518.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.